During the past decade, Greater Baltimore Medical Center and Cancer Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 23 clinical trials were completed, i.e. on average, 1150% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Greater Baltimore Medical Center and Cancer Center" #1 sponsor was "Radiation Therapy Oncology Group" with 39 trials, followed by "Eastern Cooperative Oncology Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 4 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "NSABP Foundation Inc" with 4 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Greater Baltimore Medical Center and Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 66 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "North Central Cancer Treatment Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Greater Baltimore Medical Center and Cancer Center" are "Prostate Cancer" (11 trials), "Lung Cancer" (10 trials), "Breast Cancer" (9 trials), "Head and Neck Cancer" (8 trials) and "Metastatic Cancer" (7 trials). Many other conditions were trialed in "Greater Baltimore Medical Center and Cancer Center" in a lesser frequency.

Most popular intervention types in "Greater Baltimore Medical Center and Cancer Center" are "Drug" (55 trials), "Radiation" (38 trials), "Procedure" (20 trials), "Biological" (18 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (30 trials), "paclitaxel" (11 trials), "conventional surgery" (10 trials), "cisplatin" (9 trials) and "filgrastim" (7 trials). Other intervention names were less common.

The vast majority of trials in "Greater Baltimore Medical Center and Cancer Center" are 54 trials for "All" genders, 11 trials for "Male" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Greater Baltimore Medical Center and Cancer Center". undefined are not yet recruiting, 1 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 62 completed trials in Greater Baltimore Medical Center and Cancer Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Greater Baltimore Medical Center and Cancer Center, 9 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 35 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".